参考文献/References:
[1]Takada Y,Ye X,Simon S.The integrins[J].Genome Biol,2007,8(5):215.[2]Reddy AS,Golovkin MV.Current topics in microbiology and immunology. Nuclear pre-mRNA processing in plants. Preface[J].Curr Top Microbiol Immunol,2008,326:v-vii.[3]Campbell ID,Humphries MJ.Integrin structure, activation, and interactions[J].Cold Spring Harb Perspect Biol,2011,3(3):a004994.[4]Kadry YA,Calderwood DA.Chapter 22: Structural and signaling functions of integrins[J].Biochim Biophys Acta Biomembr,2020,1862(5):183206.[5]Gahmberg CG,Gr?觟nholm M,Madhavan S,et al.Regulation of cell adhesion: a collaborative effort of integrins, their ligands, cytoplasmic actors, and phosphorylation[J].Q Rev Biophys,2019,52:e10.[6]Eble JA,Haier J.Integrins in cancer treatment[J].Curr Cancer Drug Targets,2006,6(2):89-105.[7]Desgrosellier JS,Cheresh DA.Integrins in cancer: biological implications and therapeutic opportunities[J].Nat Rev Cancer 2010,10(1):9-22.[8]Sheldrake HM,Patterson LH.Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists[J].J Med Chem,2014,57(15):6301-6315.[9]Llovet JM,Kelley RK,Villanueva A,et al.Hepatocellular carcinoma[J].Nat Rev Dis Primers,2021,7(1):6.[10]郭亚妹,徐广贤,闪明海,等.整合素α5的表达下调抑制肝癌Bel-7404细胞的增殖、侵袭及转移[J].南方医科大学学报,2020,40(6):893-898.[11]Kang CL Qi B,Cai QQ,et al.LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription[J].Theranostics,2019,9(15):4421-4436.[12]戚冰,康春兰,蔡倩倩,等.长非编码RNAAY在脑硫脂促进人肝癌细胞整合素αV表达过程的作用研究[C]//中国生物化学与分子生物学会2016年全国学术会议论文集.2016:121.[13]Chen J,Ji T,Wu D,et al.Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma[J].Cell Death Dis,2019,10(6):425.[14]周建平,周伟平.大肝癌TACE后肿瘤组织VEGF、αv整合素表达及MVD变化[J].东南国防医药,2010,12(3):206-208.[15]Peng Z,Hao M,Tong H,et al.The interactions between integrin α5β1 of liver cancer cells and fibronectin of fibroblasts promote tumor growth and angiogenesis[J].Int J Biol Sci,2022,18(13):5019-5037.[16]Lu M,Wu J,Hao ZW,et al.Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress[J].Hepatology 2018,68(1):317-332.[17]Zhang YL,Li Q,Yang XM,et al.SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways[J].Cancer Res,2018,78(9):2305-2317.[18]Yan C,Yang Q,Gong Z.Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish[J].Neoplasia,2018,20(5):533-542.[19]Yu H,Shen Y,Jin J,et al.Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade[J].Cell Adh Migr,2018,12(1):56-68.[20]Zhang C,Cao P,Yang A,et al.Downregulation of ZC3H14 driven by chromosome 14q31 deletion promotes hepatocellular carcinoma progression by activating integrin signaling[J].Carcinogenesis,2019,40(3):474-486.[21]Pan TJ, Li LX, Zhang JW,et al.Antimetastatic Effect of Fucoidan-Sargassum against Liver Cancer Cell Invadopodia Formation via Targeting Integrin αVβ3 and Mediating αVβ3/Src/E2F1 Signaling[J].J Cancer,2019,10(20):4777-4792.[22]Huang C,Li K,Huang R,et al.RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis[J].Life Sci,2021,267:118928.[23]Zheng X,Wang P,Li L,et al.Cancer-Associated Fibroblasts Promote Vascular Invasion of Hepatocellular Carcinoma via Downregulating Decorin-integrin β1 Signaling[J].Front Cell Dev Biol,2021,9:678670.[24]周彤彤,段继燕,吴志贤,等.苯胺嘧啶衍生物X-9通过下调整合素β1表达抑制肝细胞癌迁移侵袭[J].中国生物化学与分子生物学报,2020,36(2):165-173.[25]Wang C,Jiang X,Huang B,et al.Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts[J].BMC Cancer,2021,21(1):1276.[26]Huang Y,Chu P,Bao G.Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis[J].Dig Dis Sci,2021,66(11):3916-3928.[27]Sun F,Wang J,Sun Q,et al.Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma[J].J Exp Clin Cancer Res,2019,38(1):449.[28]Ding SM,Lu AL,Lu JF,et al.Macrovascular Endothelial Cells Enhance the Motility of Liver Cancer Cells by Up-regulation of MMP-3, Activation of Integrin/FAK Signaling Pathway and Induction of Non-classical Epithelial-mesenchymal Transition[J].J Cancer,2020,11(8):2044-2059.[29]Jiang K,Dong C,Yin Z,et al.Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis[J].Cell Death Dis,2020,11(11):972. [30]Lin Z,He R,Luo H,et al.Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability[J].J Exp Clin Cancer Res,2018,37(1):17.[31]Huang C,Li K, Huang R,et al.RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis[J].Life Sci,2021,267:118928.[32]Zhang L,Huang Y,Ling J,et al.Is Integrin Subunit Alpha 2 Expression a Prognostic Factor for Liver Carcinoma? A Validation Experiment Based on Bioinformatics Analysis[J].Pathol Oncol Res,2019,25(4):1545-1552. [33]Zheng G,Bouamar H,Cserhati M,et al.Integrin alpha 6 is upregulated and drives hepatocellular carcinoma progression through integrin α6β4 complex[J].Int J Cancer,2022,151(6):930-943.[34]Yang X,Song D,Zhang J,et al.PRR34-AS1 sponges miR-498 to facilitate TOMM20 and ITGA6 mediated tumor progression in HCC[J].Exp Mol Pathol,2021,120:104620.[35]Shi WK,Shang QL,Zhao YF.SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4[J].Oncol Rep,2022,47(5):91.[36]Zhang YL,Xing X,Cai LB,et al.Integrin α9 Suppresses Hepatocellular Carcinoma Metastasis by Rho GTPase Signaling[J].J Immunol Res,2018,2018:4602570.[37]Ge JC,Wang YX,Chen ZB,et al.Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma[J].Cell Signal,2020,66:109465.[38]Avraamides CJ,Garmy-Susini B,Varner JA.Integrins in angiogenesis and lymphangiogenesis[J].Nat Rev Cancer,2008,8(8):604-617.[39]Metwaly HA,El-Gayar AM,El-Shishtawy MM.Inhibition of the signaling pathway of syndecan-1 by synstatin: A promising anti-integrin inhibitor of angiogenesis and proliferation in HCC in rats[J].Arch Biochem Biophys,2018,652:50-58.[40]董小锋,钟敬涛,刘天奇,等.血管生成素-2通过整合素α5β1调控血管包绕的肿瘤细胞巢阳性肝细胞癌的癌巢转移[J].中华医学杂志,2021,101(9):654-660.[41]刘碧英,王志东.半乳糖与精氨酸-甘氨酸-天冬氨酸共修饰聚酰胺-胺树状大分子纳米粒的制备及其对肝癌的靶向性研究[J].中国现代医学杂志,2015,25(11):8-11.[42]赵伟娜,李绍东,徐凯.整合素靶向性RGD-Luc荧光探针体外显像人肝癌细胞的实验研究[J].中国校医,2015,29(9):720,封3.[43]魏新华,陈婧,杨蕊梦,等.整合素靶向性超顺磁性纳米分子探针体外显像人肝癌细胞的实验研究[J]. 中华临床医师杂志(电子版),2015(5):783-787.[44]袁海霞,王莹,关佩珊,等.双靶向整合素αvβ3及VEGFR2微泡造影剂的制备及其对肝癌细胞寻靶能力的分析[J].中华普通外科杂志,2022,37(5):378-380.[45]Li J,Zhou P,Xu H,et al.Antitumor activity of integrin αVβ3 antibody conjugated-cationic microbubbles in liver cancer[J].Transl Cancer Res,2019,8(3):899-908.[46]Tang S,Yang X,Zhou C,et al.Sodium Pump Na+/K+ATPase Subunit α1-Targeted Positron Emission Tomography Imaging of Hepatocellular Carcinoma in Mouse Models[J].Mol Imaging Biol,2022,24(3):384-393.[47]Zhang Y,Zhao J,Cai J,et al.Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice[J].Mol Imaging Biol,2020,22(4):864-872.[48]Lin YZ,Wu Y,Cao DH,et al.Integrin α6 Targeted Near Infrared Fluorescent Imaging and Photoacoustic Imaging of Hepatocellular Carcinoma in Mice[J].J Clin Transl Hepatol,2023,11(1):110-117.[49]He ZB,Niu WB,Peng C,et al.The relationship between integrin avα6 and HBV infection in patients with liver cirrhosis and hepatocellular carcinoma:a preliminary report[J].Rev Esp Enferm Dig,2020,112(6):462-466.[50]Kim YR,Byun MR,Choi JW.Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma[J].Cancer Biomark,2018,23(1):135-144.[51]李昱骥,张浩,周建平,等.β1整合素过表达抑制顺铂诱导肝癌细胞凋亡的实验研究[J].中国医科大学学报,2008,37(4):452-454,458.[52]Hou W,Bridgeman B,Malnassy G,et al.Integrin subunit beta 8 contributes to lenvatinib resistance in HCC[J].Hepatol Commun,2022,6(7):1786-1802.
相似文献/References:
[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Journal of Medical Information,2018,31(15):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Journal of Medical Information,2018,31(15):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Journal of Medical Information,2019,32(15):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Journal of Medical Information,2018,31(15):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[5]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Journal of Medical Information,2018,31(15):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[6]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的
相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Journal of Medical Information,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[7]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(15):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[8]孙 逊.性化护理对肝癌患者CT引导下射频消融术后
负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after
CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(15):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[9]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(15):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[10]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(15):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]